###begin article-title 0
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(FTO)</italic>
Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants
###end article-title 0
###begin p 1
Conceived and designed the experiments: JH AH. Performed the experiments: SF GB TM HG. Analyzed the data: JH AS TI TN HS HW AH. Contributed reagents/materials/analysis tools: WR AS TN HS. Wrote the paper: JH AS SF AH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Obesity is a major health problem. Although heritability is substantial, genetic mechanisms predisposing to obesity are not very well understood. We have performed a genome wide association study (GWA) for early onset (extreme) obesity.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 560 563 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 750 752 748 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 791 793 789 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT</sub>
###xml 842 844 840 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</sub>
###xml 1040 1043 1038 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 1103 1106 1101 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 1216 1219 1214 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 20 25 <span type="species:ncbi:9606">Human</span>
a) GWA (Genome-Wide Human SNP Array 5.0 comprising 440,794 single nucleotide polymorphisms) for early onset extreme obesity based on 487 extremely obese young German individuals and 442 healthy lean German controls; b) confirmatory analyses on 644 independent families with at least one obese offspring and both parents. We aimed to identify and subsequently confirm the 15 SNPs (minor allele frequency >/=10%) with the lowest p-values of the GWA by four genetic models: additive, recessive, dominant and allelic. Six single nucleotide polymorphisms (SNPs) in FTO (fat mass and obesity associated gene) within one linkage disequilibrium (LD) block including the GWA SNP rendering the lowest p-value (rs1121980; log-additive model: nominal p = 1.13x10-7, corrected p = 0.0494; odds ratio (OR)CT 1.67, 95% confidence interval (CI) 1.22-2.27; ORTT 2.76, 95% CI 1.88-4.03) belonged to the 15 SNPs showing the strongest evidence for association with obesity. For confirmation we genotyped 11 of these in the 644 independent families (of the six FTO SNPs we chose only two representing the LD bock). For both FTO SNPs the initial association was confirmed (both Bonferroni corrected p<0.01). However, none of the nine non-FTO SNPs revealed significant transmission disequilibrium.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 407 410 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
Our GWA for extreme early onset obesity substantiates that variation in FTO strongly contributes to early onset obesity. This is a further proof of concept for GWA to detect genes relevant for highly complex phenotypes. We concurrently show that nine additional SNPs with initially low p-values in the GWA were not confirmed in our family study, thus suggesting that of the best 15 SNPs in the GWA only the FTO SNPs represent true positive findings.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Herbert1">[1]</xref>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Wellcome1">[2]</xref>
###xml 360 363 360 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Christensen1">[3]</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Sladek1">[4]</xref>
###xml 451 454 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Ioannidis1">[7]</xref>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 515 518 515 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Frayling1">[5]</xref>
###xml 520 523 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Scott1">[6]</xref>
###xml 618 621 618 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Frayling1">[5]</xref>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 655 660 <span type="species:ncbi:9606">Human</span>
###xml 691 698 <span type="species:ncbi:9606">patient</span>
The advent of genome wide association studies (GWAs) already has had a major impact on the identification of polygenes involved in human body weight regulation [1]. However, a GWA based on obese cases and lean controls has not yet been described. GWA have recently proven extremely powerful for the detection of genes/SNPs for different complex disorders [2], [3]. The progress has been particularly impressive for type 2 diabetes mellitus (T2DM) [4]-[7]. FTO was one of the genes picked up in GWA studies for T2DM [5], [6], adjustment for BMI revealed that this effect was solely based on this quantitative phenotype [5]. We performed a GWA (Genome-Wide Human SNP Array 5.0; Affymetrix) on patient samples stemming from both ends of the BMI distribution and subsequently aimed to confirm the 15 GWA SNPs with minor allele frequency (MAF) >/=10% rendering the lowest p-values determined upon analysis of four genetic models (additive, recessive, dominant and allelic) in an independent family-based study.
###end p 9
###begin title 10
Results
###end title 10
###begin p 11
###xml 208 215 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t001">Table 1</xref>
###xml 305 306 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 324 327 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 375 382 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t001">Table 1</xref>
###xml 454 457 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 518 520 516 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 617 624 615 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t001">Table 1</xref>
###xml 923 930 921 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t001">Table 1</xref>
The GWA was analysed for the four genetic models additive, recessive, dominant and allelic. By sorting all analysed SNPs with a MAF >/=10% by minimal nominal p-values a list was derived for the best 15 SNPs (Table 1). Six SNPs (rs1121980, rs9939973, rs7193144, rs9940128, rs8050136, rs9939609, pair-wise r2 range 0.88-1) in FTO were among these 15 best SNPs of the scan (see Table 1); all six SNPs localize to the same linkage disequilibrium (LD) block. FTO-SNP rs1121980 rendered the lowest nominal p-value of 1.13x10-7; this SNP was the only SNP that survived correction for multiple testing (corrected p = 0.0494; Table 1). The log-additive OR for the rs1121980 risk T-allele was 1.66 (95% CI 1.37-2.01); the odds ratios for heterozygotes (CT) and homozygotes (TT) were estimated at 1.67 (95% CI 1.22-2.27) and 2.76 (95% CI 1.88-4.03), respectively. Frequencies of the T-allele in cases and controls were 0.53 and 0.41 (Table 1).
###end p 11
###begin title 12
###xml 77 82 <span type="species:ncbi:9606">Human</span>
Top 15 SNPs associated with early onset extreme obesity from the Genome-Wide Human SNP Array 5.0 (lowest nominal p-values across four genetic models) and their confirmation using family-based association studies for the risk allele derived from the GWA data
###end title 12
###begin p 13
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 69 72 69 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>FTO</italic></bold>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C20orf75</italic>
###xml 107 115 107 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>C20orf75</italic></bold>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSHR</italic>
###xml 149 153 149 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TSHR</italic></bold>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BC041448</italic>
###xml 203 211 203 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>BC041448</italic></bold>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCSK2</italic>
###xml 265 270 265 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>PCSK2</italic></bold>
###xml 304 312 304 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DQA2</italic>
###xml 304 312 304 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>HLA-DQA2</italic></bold>
###xml 213 225 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 272 284 <span type="species:ncbi:9606">Homo sapiens</span>
genes or transcripts according to the UCSC Genome Bioinformatics (): FTO: fat mass and obesity associated; C20orf75: hypothetical protein LOC164312; TSHR: thyroid stimulating hormone receptor isoform 1; BC041448: Homo sapiens cDNA clone IMAGE:5170949, partial cds; PCSK2: Homo sapiens cDNA FLJ34186 fis; HLA-DQA2: major histocompatibility complex, class II, DQ; none: no gene 250 kb up- or downstream of the SNP,
###end p 13
###begin p 14
FBATs were all evaluated under additive genetic model (as it is e.g. unknown if a dominant model is also appropriate for the analysis of the family-based data),
###end p 14
###begin p 15
SNPs showed evidence for a deviation from HWE in founders (p </= 0.05),
###end p 15
###begin p 16
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
not genotyped due to strong linkage disequilibrium to other FTO SNPs,
###end p 16
###begin p 17
rs41492957according to NCBI Build 36.2
###end p 17
###begin p 18
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 134 141 <span type="species:ncbi:9606">patient</span>
Eleven of the best 15 markers were subsequently genotyped in 644 independent obesity families based on at least one young obese index patient; of the six positive FTO SNPs belonging to the same LD block, we genotyped only the two SNPs with the lowest p-values. Confirmation of the initial finding using FBAT (family-based association test) was detected for the two FTO SNPs (both Bonferroni corrected p</=0.01). However, none of the risk alleles of the nine other SNPs showed evidence for association in the independent families.
###end p 18
###begin p 19
###xml 56 59 56 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Scuteri1">[8]</xref>
###xml 259 284 259 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Obesity Gene Map Database</italic>
###xml 288 291 288 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Rankinen1">[9]</xref>
###xml 493 501 493 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s001">Table S1</xref>
###xml 765 773 765 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s001">Table S1</xref>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 916 920 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDLR</italic>
###xml 1012 1013 1012 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1019 1023 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESR1</italic>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Deng1">[10]</xref>
###xml 1086 1090 1086 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Okura1">[11]</xref>
###xml 1190 1191 1190 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1231 1235 1231 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDLR</italic>
###xml 1260 1264 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Mattevi1">[12]</xref>
###xml 1266 1270 1266 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Zee1">[13]</xref>
###xml 1336 1337 1336 1337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Additionally, similar to the approach of Scuteri et al. [8], we analysed specific candidate genes (coding sequence plus approximately 50 kb flanking the 5' and 3' regions, respectively). We chose those candidate genes delineated in the current version of the Obesity Gene Map Database (; [9]), for which two or more independent positive associations to obesity have been reported in addition to those genes listed in the Database to harbour mutations leading to monogenic forms of obesity. In Table S1 (Supporting Information), for each of these genes, the SNP with the lowest p-value and the respective genetic model are shown. Overall, among the 745 SNPs tested 75 (12) had a p-value below 0.05 (0.01). We re-assessed the original publications for the markers in Table S1 (Supporting Information) which had a nominal p-value below 0.005. For three SNPs of the previous publications (ESR1: rs2234693; rs9340799 and LDLR rs688) HapMap data were available. Hence, we checked for linkage disequilibrium by D' and r2. For ESR1 both previously investigated SNPs (rs2234693; rs9340799 [10], [11]) were approximately 16 kb apart from the 500k SNP rs712221. D' was 0.321 and 0.809, respectively, r2 was 0.103 and 0.378, respectively. For LDLR the previous SNP (rs688 [12], [13]) was just 48 bp apart from the 500k SNP rs1799898. D' was 1 and r2 was 0.144. However, the allele frequencies of the original SNPs and the closest GWA SNPs were quite different (e.g. rs1799898 MAF approximately 12% versus a MAF of 45% in rs688), complicating statements dealing with whether or not both markers tag the same disease related haplotype. Clearly, this possibility requires further attention.
###end p 19
###begin title 20
Discussion
###end title 20
###begin p 21
###xml 166 168 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 203 206 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 285 288 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 352 355 348 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Frayling1">[5]</xref>
###xml 357 360 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Scott1">[6]</xref>
###xml 441 444 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 660 663 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Frayling1">[5]</xref>
###xml 756 760 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Dina1">[14]</xref>
###xml 830 833 826 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Scuteri1">[8]</xref>
###xml 886 890 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Dina1">[14]</xref>
###xml 919 921 915 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1137 1138 1133 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1323 1327 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Garner1">[15]</xref>
###xml 1042 1050 <span type="species:ncbi:9606">children</span>
Here we show by a GWA including early onset extremely obese cases (mean BMI Zscore 4.63+/-2.27) and healthy underweight controls (mean BMI Zscore -1.38+/-0.35; BMI<15th age percentile) that variation in FTO strongly contributes to the development of early onset obesity. Recently, the FTO gene was found to be associated with T2DM as based on two GWAs [5], [6]. However, after adjusting for BMI the T2DM association vanished indicating that FTO explains variation of body weight. Confirmation in 13 samples with 38,759 individuals and a meta-analysis showed that the A-allele of the variant rs9939609 is associated with a 31% increased risk to develop obesity [5]. These results were independently supported in 8,000 individuals from different populations [14] and in a GWA for obesity-related traits in an epidemiological cohort [8]. The best SNP rs1421085 of the study of Dina et al. [14] showed a nominal p = 3.46x10-7 (log-additive OR for the risk allele 1.69, 95% CI 1.38-2.06) in a case-control sample which also comprised obese German children. For our best SNP rs1121980, which is located 8.3 kb upstream of rs1421085 (pairwise r2 = 0.90 in CEU HAPMAP; both within intron 1), we found similar estimated genetic effect sizes. As effect sizes for the best markers derived from GWA data sets are usually overestimated [15], our GWA data is an example that this will not always be the case.
###end p 21
###begin p 22
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Frayling1">[5]</xref>
###xml 287 290 287 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Scuteri1">[8]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Dina1">[14]</xref>
###xml 771 774 771 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Frayling1">[5]</xref>
###xml 877 880 877 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 262 270 <span type="species:ncbi:9606">children</span>
###xml 345 353 <span type="species:ncbi:9606">children</span>
###xml 911 919 <span type="species:ncbi:9606">children</span>
Given the relatively small sample size used in our GWA, this investigation nevertheless revealed a single SNP in FTO that remained significant after a proper control of the type I error. The FTO SNPs have previously been shown to be relevant for obesity in both children and adults [5], [8], [14]. To determine, if the finding is present in all children or only among the older teenagers we did a median split for age within the case group and explored the relationship of each subgroup in comparison to controls as well as to each other (data not shown). The effect is valid in both subgroups and there is no difference between the subgroups. Frayling et al. reported that the association is relevant by the age of 7 and persists into the pre-pubertal period and beyond [5]. Only a meta-analysis addressing developmental aspects will be able to pinpoint, if the effect of the FTO variants is more relevant for children or for adults.
###end p 22
###begin p 23
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 111 118 111 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t001">Table 1</xref>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 380 383 380 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Scuteri1">[8]</xref>
Confirmation of the 11 SNPs genotyped in 644 independent obesity families succeeded only for the two FTO SNPs (Table 1). Hence, our data suggest that of the best 15 SNPs of the GWA only the FTO SNPs represent true positive findings. This is in accordance with a population-based GWA for body weight that also merely resulted in the initial confirmation of only one candidate gene [8].
###end p 23
###begin p 24
###xml 52 60 52 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s001">Table S1</xref>
###xml 270 295 270 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Obesity Gene Map Database</italic>
###xml 299 302 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Rankinen1">[9]</xref>
Our data pertaining to the candidate gene analyses (Table S1) are not readily comparable with the previous publications, as for instance the number of analysed individuals was quite low for some of the previous reports. We restricted our analyses to genes listed in the Obesity Gene Map Database (; [9]) with at least two confirmations; the quality of the original reports varied considerably and for some of the genes different SNPs/variants had been analysed. Hence, we suggest that the candidate genes with SNPs resulting in nominal p-values below 0.005 in our scan should be followed up in subsequent studies.
###end p 24
###begin p 25
In general, this report is another proof of concept in favour of GWAs contributing to the investigation of common variation in complex phenotypes.
###end p 25
###begin title 26
Methods
###end title 26
###begin title 27
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants
###end title 27
###begin p 28
###xml 143 150 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t002">Table 2</xref>
###xml 278 285 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t002">Table 2</xref>
###xml 845 852 843 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s003">Text S1</xref>
###xml 1087 1114 1085 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The Declaration of Helsinki</italic>
###xml 20 28 <span type="species:ncbi:9606">children</span>
###xml 897 909 <span type="species:ncbi:9606">participants</span>
487 extremely obese children and adolescents ('cases') were recruited in hospitals specialized for the inpatient treatment of extreme obesity (Table 2; mean BMI Z score: 4.63+/-2.27) while 442 healthy lean individuals ('controls') were ascertained at the University of Marburg (Table 2). We relied on older healthy underweight controls to substantially reduce the probability of their becoming overweight and to increase power [e.g. 16]. Based on self-reported questionnaire data on body-weight course, 78% of the lean controls reported having had a below average body weight at age 15, which is similar to the mean age of our obese cases. Thus, our control group mainly comprises individuals who presumably also were in the lower body weight range during adolescence. Details on power considerations are provided in the Supporting Information (Text S1). Written informed consent was given by all participants and in case of minors their parents. The study was approved by the Ethics Committees of the Universities of Marburg and Essen and conducted in accordance with the guidelines of The Declaration of Helsinki.
###end p 28
###begin title 29
###xml 54 59 <span type="species:ncbi:9606">Human</span>
Description of samples genotyped with the Genome-Wide Human SNP Array 5.0 and the obesity families used for confirmation of the 11 best SNPs
###end title 29
###begin title 30
Genotyping
###end title 30
###begin p 31
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Vollmert1">[17]</xref>
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Genotyping was performed on the Genome-Wide Human SNP Array 5.0 () at the Affymetrix Services Lab (California, USA). 440,794 genotypes of 929 individuals (Dynamic Model algorithm call rate>86%) were called by the BRLMM-P algorithm. For the replication of 11 SNPs genotyping was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis of allele-dependent primer extension products as described elsewhere [17].
###end p 31
###begin title 32
Statistical Methods
###end title 32
###begin p 33
###xml 280 287 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s003">Text S1</xref>
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s002">Table S2</xref>
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001361-Sladek1">[4]</xref>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s003">Text S1</xref>
For the GWA data, SNPs with a call rate<95%, departure from Hardy-Weinberg equilibrium in the control group (exact test p<0.01), or with minor allele frequency below 10 percent were excluded from the final analysis (151,503 excluded; 289,291 retained; see Supporting Information; Text S1 and Table S2). The statistical analyses followed the procedure of Sladek et al. [4]. Details are described in the Supporting Information (Text S1). All reported nominal p-values of the GWA are two-sided and asymptotic. In addition, empirical p-values corrected for genome-wide testing and maximization across genetic models are provided. We used a genome-wide significance level of .05 (two-sided). For the confirmation study, both nominal one-sided and Bonferroni corrected (11 tests) p-values are presented for the risk alleles identified in the GWA.
###end p 33
###begin title 34
Confirmation
###end title 34
###begin p 35
###xml 86 93 86 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t001">Table 1</xref>
###xml 333 340 333 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001361-t002">Table 2</xref>
###xml 177 185 <span type="species:ncbi:9606">children</span>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
The 11 of the 15 best SNPs (ranked by p-value, irrespective of the genetic model; see Table 1) were genotyped in 644 independent obesity families comprising 644 extremely obese children and adolescents (index patients) and both of their biological parents; additionally in 297 families obese sibs were also included (for details see Table 2). As none of the 11 SNPs showed strong evidence for a recessive genetic model in the GWA, it was decided to restrict the family-based association testing to the additive model for each of the SNPs (FBAT additive) in order to reduce the amount of multiple testing.
###end p 35
###begin title 36
Candidate gene analyses
###end title 36
###begin p 37
###xml 363 388 363 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Obesity Gene Map Database</italic>
###xml 598 606 596 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001361.s001">Table S1</xref>
Within the GWA data we analysed genes previously suggested to be involved in body weight regulation. We examined 745 SNPs (located within the gene and approximately 50kb 5'and 50kb 3'to the gene) in 47 candidate genes (single gene mutations with an obesity phenotype and candidate genes associated with obesity in at least two independent studies as shown in the Obesity Gene Map Database; ) and determined the number of SNPs with p-values </= 0.05 (0.01). In addition, we provided information on the SNP with the lowest p-value among all tested genetic models for the respective candidate gene in Table S1 (Supporting Information). For markers which had a nominal p-value below 0.005 we re-assessed the original publications in order to figure out if the marker in our GWA scan matches the information provided in the original publications.
###end p 37
###begin title 38
Supporting Information
###end title 38
###begin p 39
###xml 54 76 54 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">human obesity gene map</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Analyses of obesity candidate genes (according to the human obesity gene map: the 2005 update: Rankinen et al., 2006) in the GWA approach
###end p 39
###begin p 40
(0.16 MB DOC)
###end p 40
###begin p 41
Click here for additional data file.
###end p 41
###begin p 42
Genotyping and quality control
###end p 42
###begin p 43
(0.08 MB DOC)
###end p 43
###begin p 44
Click here for additional data file.
###end p 44
###begin p 45
Genotyping and quality control; Additional information on statistical analyses; References for the Supporting Information.
###end p 45
###begin p 46
(0.04 MB DOC)
###end p 46
###begin p 47
Click here for additional data file.
###end p 47
###begin p 48
We thank the probands for their participation.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
A common genetic variant is associated with adult and childhood obesity.
###end article-title 50
###begin article-title 51
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 51
###begin article-title 52
What genome-wide association studies can do for medicine.
###end article-title 52
###begin article-title 53
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 53
###begin article-title 54
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
###end article-title 54
###begin article-title 55
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 55
###begin article-title 56
Heterogeneity in meta-analyses of genome-wide association investigations.
###end article-title 56
###begin article-title 57
Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits.
###end article-title 57
###begin article-title 58
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human obesity gene map: the 2005 update.
###end article-title 58
###begin article-title 59
###xml 113 118 <span type="species:ncbi:9606">women</span>
Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women.
###end article-title 59
###begin article-title 60
Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution.
###end article-title 60
###begin article-title 61
Association of the low-density lipoprotein receptor gene with obesity in Native American populations.
###end article-title 61
###begin article-title 62
Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives.
###end article-title 62
###begin article-title 63
Variation in FTO contributes to childhood obesity and severe adult obesity.
###end article-title 63
###begin article-title 64
Upward bias in odds ratio estimates from genome-wide association studies.
###end article-title 64
###begin article-title 65
Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies.
###end article-title 65
###begin article-title 66
Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study.
###end article-title 66
###begin p 67
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 67
###begin p 68
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Bundesministerium fur Bildung und Forschung (NGFN2 01GS0482, 01GS0483 and 01GP0259, 01GP0209), the Deutsche Forschungsgemeinschaft (HE 1446/4-1) and the European Union (FP6 LSHMCT-2003-503041). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 68

